The influence of 1-(5-oxohexyl-)3.7-dimethylxanthine (BL 191) on the endocrine and exocrine pancreatic function in man during and following secretin and cholecystokinin-pancreozymin stimulation.
D001786:Blood Glucose / Q000032:analysis; D002766:Cholecystokinin / Q000494:pharmacology*; D000242:Cyclic AMP / Q000494:pharmacology; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects*; D010179:Pancreas / Q000187:drug effects* / Q000378:metabolism; D011863:Radioimmunoassay; D011941:Receptors, Adrenergic / Q000187:drug effects; D012633:Secretin / Q000494:pharmacology*; D014970:Xanthines / Q000494:pharmacology*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D011941:Receptors, Adrenergic; D014970:Xanthines; D012633:Secretin; D002766:Cholecystokinin; D000242:Cyclic AMP